Maria Mar Hernandez Guillamon Senior Researcher, Neurovascular Research Lab, VHIR. Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Twitter Email Maria Mar Hernandez Guillamon Twitter Email Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Senior Researcher, Neurovascular Research Lab, VHIR.
Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.
Projects Estudio de la implicación de la distribución de la apolipoproteína J (ApoJ/Clusterin) en lipoproteínas circulantes en la Angiopatía Amiloide Cerebral IP: Maria Mar Hernandez Guillamon Collaborators: Guillem Colell Dinares, David Rodriguez Luna Funding agency: Instituto de Salud Carlos III Funding: 110715 Reference: PI17/00275 Duration: 01/01/2018 - 31/12/2020 Impact of time to achieve blood pressure control on hematoma expansion in patients with acute intracerebral hemorrhage IP: David Rodriguez Luna Collaborators: Maria Mar Hernandez Guillamon, Mª Ángeles Muchada López Funding agency: Fundació La Marató de TV3 Funding: 177052.88 Reference: 20173030 Duration: 01/01/2018 - 31/01/2022 Sol·licitud de la Dra. Mar Hernández dels contractes Miguel Servet II IP: Joan Montaner Villalonga Collaborators: Maria Mar Hernandez Guillamon, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 101250 Reference: CPII17/00010 Duration: 01/01/2018 - 31/12/2020 Therapeutic effect of rApoA-I-Milano in an AD model IP: Maria Mar Hernandez Guillamon Collaborators: Anna Penalba Morenilla Funding agency: BrightFocus Foundation Funding: 254465.28 Reference: RAPOA-I-MILANO_BRIGTHFOCUSF2017 Duration: 01/07/2017 - 30/06/2021 Pagination First page « Previous page ‹ … Page 2 Page 3 Current page 4 Page 5 Page 6 … Next page › Last page »
